Schedule 13G ownership disclosure

Melinta Therapeutics Inc

Security class unavailable · CUSIP: 58549G100

Event date: 2018-10-24

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,474,761
Percent of class
6.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-18-000598
Form type
SC 13G
Filer
MELINTA THERAPEUTICS, INC. /NEW/
CIK
CIK 1461993
Filed
Nov 02, 2018
Reporting period
Oct 24, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub